These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6809110)

  • 21. Predictors for relapse after antiepileptic drug withdrawal in seizure-free patients with epilepsy.
    Su L; Di Q; Yu N; Zhang Y
    J Clin Neurosci; 2013 Jun; 20(6):790-4. PubMed ID: 23632288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiepileptic polypharmacy, psychosocial behaviour and locus of control orientation among mentally handicapped adults living in the community.
    Espie CA; Gillies JB; Montgomery JM
    J Ment Defic Res; 1990 Aug; 34 ( Pt 4)():351-60. PubMed ID: 2398491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse following discontinuation of antiepileptic drugs: a meta-analysis.
    Berg AT; Shinnar S
    Neurology; 1994 Apr; 44(4):601-8. PubMed ID: 8164811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of SARS on epilepsy: the experience of drug withdrawal in epileptic patients.
    Lai SL; Hsu MT; Chen SS
    Seizure; 2005 Dec; 14(8):557-61. PubMed ID: 16188463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid versus slow withdrawal of antiepileptic drugs.
    Ranganathan LN; Ramaratnam S
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005003. PubMed ID: 16625621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation of antiepileptic drug treatment in controlled seizure patients.
    Uesugi H; Kojima T; Miyasaka M; Matsuura M; Ohtaka T; Moriiwa M; Shimazono Y
    Jpn J Psychiatry Neurol; 1994 Jun; 48(2):255-8. PubMed ID: 7807741
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and therapeutic monitoring of epilepsy in a mental handicap unit.
    Collacott RA; Dignon A; Hauck A; Ward JW
    Br J Psychiatry; 1989 Oct; 155():522-5. PubMed ID: 2611575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of seizure-free patients and risk factors of relapse following antiepileptic drug withdrawal.
    Ou S; Xia L; Li R; Wang L; Xia L; Zhou Q; Pan S
    Epilepsy Behav; 2018 Nov; 88():295-300. PubMed ID: 30340125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural changes in patients with intellectual disability treated with perampanel.
    Andres E; Kerling F; Hamer H; Kasper B; Winterholler M
    Acta Neurol Scand; 2017 Dec; 136(6):645-653. PubMed ID: 28568478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment with antiepileptic agents in patients with mental retardation and multiple handicaps].
    Brodtkorb E
    Tidsskr Nor Laegeforen; 2001 Mar; 121(7):834-5. PubMed ID: 11301710
    [No Abstract]   [Full Text] [Related]  

  • 31. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
    Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW
    Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps.
    Mattson RH
    Epilepsia; 1996; 37 Suppl 6():S45-53. PubMed ID: 8941041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The withdrawal of antiepileptic medication].
    Pinto F
    Acta Med Port; 1997; 10(8-9):581-4. PubMed ID: 9446477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.
    Pitkänen A; Ylinen A; Matilainen R; Luukkainen R; Mervaala E; Seppänen R; Ruutiainen T; Riekkinen PJ
    Arch Neurol; 1993 Jan; 50(1):24-9. PubMed ID: 8418797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitrazepam in the treatmet of epilepsy in childhood.
    Jan JE; Riegl JA; Crichton JU; Dunn HG
    Can Med Assoc J; 1971 Apr; 104(7):571-5. PubMed ID: 5550546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation.
    McKee JR; Sunder TR; Vuong A; Hammer AE
    J Child Neurol; 2006 May; 21(5):372-9. PubMed ID: 16901441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The retention of lacosamide in patients with epilepsy and intellectual disability in three specialised institutions.
    Brenner J; Majoie HJM; van Beek S; Carpay JA
    Seizure; 2017 Nov; 52():123-130. PubMed ID: 29031193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing therapy of seizures in children and adolescents with developmental disabilities.
    Smith MC
    Neurology; 2006 Dec; 67(12 Suppl 4):S52-5. PubMed ID: 17190924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical therapeutics. Management of epilepsy: therapeutic aspects.
    Bahemuka M
    East Afr Med J; 1981 Jun; 58(6):389-400. PubMed ID: 7308094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.